Marpai, Inc. (MRAI)

USD 1.06

(-4.5%)

EBITDA Summary of Marpai, Inc.

Marpai, Inc.'s latest annual EBITDA in 2023 was -20.97 Million USD , up 5.99% from previous year.
Marpai, Inc.'s latest quarterly EBITDA in 2024 Q2 was -11.35 Million USD , down -272.18% from previous quarter.
Marpai, Inc. reported an annual EBITDA of -22.54 Million USD in 2022, down -63.73% from previous year.
Marpai, Inc. reported an annual EBITDA of -13.79 Million USD in 2021, down -327.24% from previous year.
Marpai, Inc. reported a quarterly EBITDA of -3.05 Million USD for 2024 Q1, down -10.37% from previous quarter.
Marpai, Inc. reported a quarterly EBITDA of -4.49 Million USD for 2023 Q3, up 23.5% from previous quarter.

Annual EBITDA Chart of Marpai, Inc. (2023 - 2019)

Historical Annual EBITDA of Marpai, Inc. (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-20.97 Million USD	5.99%
2022	-22.54 Million USD	-63.73%
2021	-13.79 Million USD	-327.24%
2020	-3.18 Million USD	-110.52%
2019	-1.51 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-11.35 Million USD	-272.18%
2024 Q1	-3.05 Million USD	-10.37%
2023 Q3	-4.49 Million USD	23.5%
2023 FY	- USD	5.99%
2023 Q2	-5.87 Million USD	18.15%
2023 Q1	-7.17 Million USD	4.79%
2023 Q4	-2.76 Million USD	38.46%
2022 Q4	-7.53 Million USD	-68.77%
2022 Q3	-4.46 Million USD	23.49%
2022 Q2	-5.83 Million USD	-26.05%
2022 Q1	-4.63 Million USD	5.3%
2022 FY	- USD	-63.73%
2021 Q3	-3.87 Million USD	-10.85%
2021 FY	- USD	-327.24%
2021 Q4	-4.89 Million USD	-26.06%
2021 Q2	-3.49 Million USD	-157.38%
2021 Q1	-1.35 Million USD	-97.56%
2020 Q3	-747.3 Thousand USD	14.13%
2020 Q2	-870.32 Thousand USD	6.87%
2020 Q4	-688.2 Thousand USD	7.91%
2020 Q1	-934.51 Thousand USD	-34.31%
2020 FY	- USD	-110.52%
2019 Q4	-695.77 Thousand USD	0.0%
2019 FY	- USD	0.0%

Peer EBITDA Comparison of Marpai, Inc.

Name	EBITDA	EBITDA Difference
Alignment Healthcare, Inc.	-105.29 Million USD	80.08%
Clover Health Investments, Corp.	-210.84 Million USD	90.052%
NewGenIvf Group Limited	-2.52 Million USD	-731.793%